The chemokine system and cancer

Journal of Pathology - Tập 226 Số 2 - Trang 148-157 - 2012
Frances R. Balkwill1
1Centre for Cancer and Inflammation, Barts Cancer Institute, London, UK

Tóm tắt

Abstract

Chemokines (chemo‐attractant cytokines) are a group of small proteins that act together with their cell surface receptors, in development, normal physiology and immune responses, to direct cells to specific locations throughout the body. Cancer cells acquire the ability to subvert the chemokine system, such that these molecules and their receptors become important regulators of cell movement into and out of the tumour microenvironment and major players in cancer biology. Copyright © 2011 Pathological Society of Great Britain and Ireland. Published by John Wiley & Sons, Ltd.

Từ khóa


Tài liệu tham khảo

10.1016/j.yexcr.2011.01.005

10.1038/nri2972

10.1016/S1074-7613(00)80165-X

10.1002/eji.200737215

10.1038/nrc1388

10.1016/j.yexcr.2010.11.013

10.1016/j.cytogfr.2009.11.007

10.1016/j.semcancer.2003.10.003

10.1038/nri3049

10.1016/j.immuni.2010.04.017

10.1172/JCI30068

10.1084/jem.20070608

10.4049/jimmunol.177.1.17

10.1038/nature01338

10.1016/j.pharmthera.2011.06.008

10.1038/nature07205

10.1073/pnas.0503039102

10.1158/0008-5472.CAN-06-0981

10.1016/j.ccr.2007.01.012

10.1016/j.ccr.2004.09.028

10.1038/nm1649

10.1101/gad.2038411

10.1038/nature01874

10.1158/0008-5472.CAN-07-5597

10.1038/sj.onc.1210120

Katoh M, 2010, Integrative genomic analyses of CXCR4: transcriptional regulation of CXCR4 based on TGFβ, Nodal, Activin signaling and POU5F1, FOXA2, FOXC2, FOXH1, SOX17, and GFI1 transcription factors, Int J Oncol, 36, 415

10.1073/pnas.0705673104

10.1182/blood-2009-07-235184

10.1136/gut.2009.183772

10.1038/nature10138

10.1126/science.6828888

10.1016/j.cell.2010.03.014

10.1016/j.cytogfr.2009.11.009

10.1172/JCI30068

10.1084/jem.20101876

10.1038/nature10169

10.1158/0008-5472.CAN-10-0427

10.1158/1078-0432.CCR-09-2329

10.1084/jem.20030267

Bachelder RE, 2002, Vascular endothelial growth factor promotes breast carcinoma invasion in an autocrine manner by regulating the chemokine receptor CXCR4, Cancer Res, 62, 7203

10.1210/me.2002-0438

10.1074/jbc.M300609200

10.1158/0008-5472.CAN-06-2941

10.1093/jnci/93.21.1638

10.1189/jlb.1105633

10.1158/1078-0432.CCR-07-2025

10.1016/j.jneuroim.2010.05.007

10.1016/j.cytogfr.2009.11.001

10.1038/sj.onc.1209505

10.1038/sj.onc.1210751

10.1158/0008-5472.CAN-09-3642

10.1158/0008-5472.CAN-09-0374

10.1093/jnci/djn059

10.1002/jcb.22056

10.1093/jnci/djp266

10.1200/JCO.2007.11.2136

10.1158/1078-0432.CCR-11-0945

10.1007/s00262-008-0632-0

10.1517/14728222.2011.586634

10.1007/s10585-007-9133-3

10.1002/pros.21008

10.1182/blood-2003-02-0663

10.1016/j.bcp.2008.12.014

10.1056/NEJMoa1104621

10.1016/j.ccr.2008.08.001

10.1016/j.cytogfr.2009.11.008

10.4049/jimmunol.0903846